Although insight into the intricate nature of metabolic cooperation between the tumor cells and various host cells that it interacts within the microenvironment are emerging at the present, their potential as therapeutic targets is already indicated by the encouraging results from the studies with modifiers of lactate transport (MCT1) (17, 262). Here, SLC16A1 is linked to neoplasm.